癌症突变汇聚在一组蛋白质组件上,以预测对复制应激的抵抗力
Xiaoyu Zhao1, Akshat Singhal2, Sungjoon Park1
1Division of Human Genomics and Precision Medicine, Department of Medicine, University of California, San Diego, La Jolla, California.
癌症突变通过复杂的分子途径影响药物反应. 这项研究使用深度学习来预测这些突变如何影响对复制应激诱导剂的敏感性,揭示了精准医学的关键抵抗机制.
科学领域:
- 在瘤学瘤学.
- 计算生物学 计算生物学
- 遗传学 是一个遗传学.
背景情况:
- 癌细胞的快速增殖使它们对导致DNA复制应激 (RS) 的疗法敏感.
- 然而,许多瘤通过不太了解的分子通路发展出抵抗力.
- 识别这些途径对于开发有效的癌症治疗至关重要.
研究的目的:
- 开发预测模型,阐明癌症突变如何影响对常见复制应激诱导 (RSi) 剂的反应.
- 解释药物反应和耐药性的机制基础.
- 识别控制药物敏感性的分子组合和遗传改变.
主要方法:
- 一组深度学习预测模型用于多药反应预测.
- 在数百个基因中整合基因变异.
- 功能丧失的基因选以验证已识别的分子组合.
- 模型应用于患者数据 (用cisplatin治疗的宫癌).
主要成果:
- 确定了41个分子组合,整合了数百个基因变异,以准确预测药物反应.
- 其中30个组件通过遗传选显示可以调节药物敏感性或复制重启.
- 突出了RTK-JAK-STAT组合作为西斯丁治疗宫癌患者耐药性的关键机制.
结论:
- 定义了癌症突变影响治疗反应的机制汇编.
- 证明了深度学习对预测药物反应和解释耐药机制的有用性.
- 这些发现对推进瘤学领域的精准医学有重大意义.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10:32Detection of Post-Replicative Gaps Accumulation and Repair in Human Cells Using the DNA Fiber Assay
Published on: February 3, 2022
相关概念视频
The DNA Replication Fork
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Cancers Originate from Somatic Mutations in a Single Cell
DNA Damage can Stall the Cell Cycle
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
